NOELLE MUNDT: Open Payments
NPI 1598726572 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 65 payments from 10 companies in 2025. Trend: 2023 $2,116 · 2024 $1,642 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $304 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $154 |
| Celltrion USA Inc. | 9 | $142 |
| Phathom Pharmaceuticals, Inc. | 7 | $127 |
| Regeneron Healthcare Solutions, Inc. | 5 | $95 |
| Janssen Biotech, Inc. | 4 | $82 |
| Lilly USA, LLC | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Ardelyx, Inc. | 1 | $21 |
| GENZYME CORPORATION | 1 | $17 |
Products named: RINVOQ, VEGZELMA, VOQUEZNA, LINZESS, ENTYVIO, DUPIXENT, TREMFYA, OMVOH.
Industry payments across IA — which companies pay providers there.
